276 related articles for article (PubMed ID: 24184344)
21. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
Kambayashi A; Blume H; Dressman JB
Eur J Pharm Biopharm; 2014 Jul; 87(2):236-43. PubMed ID: 24462791
[TBL] [Abstract][Full Text] [Related]
22. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
Münster M; Schoch C; Schmidt C; Breitkreutz J
Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
[TBL] [Abstract][Full Text] [Related]
23. Structural and in vitro in vivo evaluation for taste masking.
Al-Kasmi B; Al Rahal O; El-Zein H; Nattouf AH
Expert Opin Drug Deliv; 2018 Nov; 15(11):1105-1116. PubMed ID: 30311503
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of taste-masking effects of pharmaceutical sweeteners with an electronic tongue system.
Choi du H; Kim NA; Nam TS; Lee S; Jeong SH
Drug Dev Ind Pharm; 2014 Mar; 40(3):308-17. PubMed ID: 23786206
[TBL] [Abstract][Full Text] [Related]
25. Taste Masking Approaches for Medicines.
Faisal W; Farag F; Abdellatif AAH; Abbas A
Curr Drug Deliv; 2018 Feb; 15(2):167-185. PubMed ID: 29034835
[TBL] [Abstract][Full Text] [Related]
26. Recent patents and patented technology platforms for pharmaceutical taste masking.
Kaushik D; Dureja H
Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):37-45. PubMed ID: 24499438
[TBL] [Abstract][Full Text] [Related]
27. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
[TBL] [Abstract][Full Text] [Related]
28. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
[TBL] [Abstract][Full Text] [Related]
29. Application and validation of an advanced gastrointestinal in vitro model for the evaluation of drug product performance in pharmaceutical development.
Barker R; Abrahamsson B; Kruusmägi M
J Pharm Sci; 2014 Nov; 103(11):3704-3712. PubMed ID: 25223814
[TBL] [Abstract][Full Text] [Related]
30. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
Heigoldt U; Sommer F; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
[TBL] [Abstract][Full Text] [Related]
31. Paediatric oral biopharmaceutics: key considerations and current challenges.
Batchelor HK; Fotaki N; Klein S
Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
[TBL] [Abstract][Full Text] [Related]
32. Development and optimisation of simulated salivary fluid for biorelevant oral cavity dissolution.
Ali J; Bong Lee J; Gittings S; Iachelini A; Bennett J; Cram A; Garnett M; Roberts CJ; Gershkovich P
Eur J Pharm Biopharm; 2021 Mar; 160():125-133. PubMed ID: 33524535
[TBL] [Abstract][Full Text] [Related]
33. Hot melt extrusion of ion-exchange resin for taste masking.
Tan DCT; Ong JJ; Gokhale R; Heng PWS
Int J Pharm; 2018 Aug; 547(1-2):385-394. PubMed ID: 29859323
[TBL] [Abstract][Full Text] [Related]
34. Orally disintegrating dosage forms and taste-masking technologies; 2010.
Douroumis D
Expert Opin Drug Deliv; 2011 May; 8(5):665-75. PubMed ID: 21438776
[TBL] [Abstract][Full Text] [Related]
35. Dissolution testing of oral modified-release dosage forms.
Garbacz G; Klein S
J Pharm Pharmacol; 2012 Jul; 64(7):944-68. PubMed ID: 22686342
[TBL] [Abstract][Full Text] [Related]
36. Electronic tongue for pharmaceutical analytics: quantification of tastes and masking effects.
Legin A; Rudnitskaya A; Clapham D; Seleznev B; Lord K; Vlasov Y
Anal Bioanal Chem; 2004 Sep; 380(1):36-45. PubMed ID: 15365669
[TBL] [Abstract][Full Text] [Related]
37. Development of oral acetaminophen chewable tablets with inhibited bitter taste.
Suzuki H; Onishi H; Takahashi Y; Iwata M; Machida Y
Int J Pharm; 2003 Jan; 251(1-2):123-32. PubMed ID: 12527182
[TBL] [Abstract][Full Text] [Related]
38. Melt extrusion: process to product.
Repka MA; Shah S; Lu J; Maddineni S; Morott J; Patwardhan K; Mohammed NN
Expert Opin Drug Deliv; 2012 Jan; 9(1):105-25. PubMed ID: 22145932
[TBL] [Abstract][Full Text] [Related]
39. Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.
Tiwari RV; Polk AN; Patil H; Ye X; Pimparade MB; Repka MA
AAPS PharmSciTech; 2017 Feb; 18(2):341-348. PubMed ID: 26573158
[TBL] [Abstract][Full Text] [Related]
40. An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods.
Hu S; Liu X; Zhang S; Quan D
AAPS PharmSciTech; 2023 Feb; 24(2):67. PubMed ID: 36788171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
